May 2, 2023 05:47AM
May 1, 2023 09:00PM
Apr 18, 2023 04:52PM
Apr 18, 2023 04:30PM
Apr 18, 2023 07:34AM
Apr 18, 2023 07:30AM
Mar 30, 2023 02:25PM CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Mar 30, 2023 02:25PM
Mar 29, 2023 04:15PM
Jan 18, 2023 07:31AM
Jan 18, 2023 07:30AM
Jan 11, 2023 04:30PM
Jan 9, 2023 05:11AM
Jan 6, 2023 08:00PM OpGen Announces Pricing of $7.5 Million Public Offering
Dec 13, 2022 07:34AM
Dec 13, 2022 07:30AM
Nov 10, 2022 04:10PM
Oct 25, 2022 07:31AM
Oct 25, 2022 07:30AM
Oct 3, 2022 04:20PM
Oct 3, 2022 07:30AM OpGen Announces Successful Completion of Clinical Trial Enrollment for Unyvero Urinary Tract Infection Panel
Sep 30, 2022 08:38AM
Sep 30, 2022 08:37AM
Aug 11, 2022 04:15PM
Jun 22, 2022 08:01AM
Jun 22, 2022 08:00AM
Jun 22, 2022 07:30AM
May 26, 2022 07:30AM OpGen (OPGN) Reports Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel
May 26, 2022 07:30AM
May 12, 2022 04:15PM
Apr 5, 2022 07:33AM
Apr 5, 2022 07:30AM
Mar 29, 2022 04:05PM
Feb 10, 2022 04:30PM
Feb 10, 2022 07:31AM OpGen (OPGN) Successfully Completes Unyvero A30 Development Milestone
Feb 10, 2022 07:30AM
Jan 10, 2022 07:33AM
Jan 10, 2022 07:30AM
Nov 11, 2021 04:05PM
Nov 4, 2021 07:31AM
Nov 4, 2021 07:30AM
Oct 18, 2021 04:30PM OpGen Announces Closing of $15 Million Registered Direct Offering
Oct 14, 2021 08:01AM
Oct 14, 2021 08:00AM
Oct 4, 2021 07:33AM
Oct 4, 2021 07:33AM
Oct 4, 2021 07:30AM
Oct 4, 2021 07:30AM
Sep 30, 2021 07:30AM OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel
Sep 15, 2021 07:32AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All